Changes in gastrointestinal motility influence the absorption of desmopressin

被引:15
作者
Callréus, T
Lundahl, J
Höglund, P [1 ]
Bengtsson, P
机构
[1] Univ Lund Hosp, Dept Clin Pharmacol, SE-22185 Lund, Sweden
[2] Ferring Pharmaceut, Malmo, Sweden
关键词
gastrointestinal motility; absorption; desmopressin;
D O I
10.1007/s002280050633
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The antidiuretic effect of desmopressin is widely utilized in the treatment of neurogenic diabetes insipidus and nocturnal enuresis in children. The objective of the present study was to assess how changes in gastrointestinal motility, induced by erythromycin and loperamide, influence the pharmacokinetics of orally administered desmopressin. Methods: This study was conducted using an open randomized, three-period, three-treatment design in 18 healthy subjects. On each study day a single oral dose of 400 mu g desmopressin was administered in the morning. The desmopressin dose was either given alone (reference) or after pretreatment with either loperamide tablets (4 mg at -24, -12 h and -1 h) or erythromycin capsules (250 mg q.i.d, with the first dose in the morning 3 days before the study day and the last dose at -1 h). On each study day, blood was sampled up to 8 h after dosing for assessment of desmopressin concentration. Results: Compared with administration of 400 mu g of desmopressin alone, pretreatment with loperamide produced significantly(P < 0.05) altered pharmacokinetics of desmopressin as the endpoints; area under the curve up to infinity (AUC), area up to the last determinable plasma concentration (AUC,) and maximum plasma concentration (C-max) increased 3.1-fold (95% CI 2.3-4.2), 3.2 (2.3-4.4) and 2.3 (1.6-3.2), respectively. Although the estimates were lower, pretreatment with erythromycin did not result in any significant changes in these endpoints. There were no significant changes observed between the three treatments regarding the terminal elimination half-life (t(1/2)) However, significant (P < 0.05) changes in the time to reach C-max (t(max)) values (median and range) were observed as, compared with administration of desmopressin alone (1.3 h and 0.5-4.0), it was longer after pretreatment with loperamide (2.0 h and 0.5-3.0) and shorter following pretreatment with erythromycin (0.9 h and 0.5-1.3). Conclusion: Presumably due to slower gastrointestinal motility, pretreatment with loperamide significantly increases the gastrointestinal absorption of desmopressin. Except for a shortening of t(max), pretreatment with erythromycin did not significantly influence absorption of the drug.
引用
收藏
页码:305 / 309
页数:5
相关论文
共 16 条
[1]  
[Anonymous], 1990, DRUG INVEST, DOI [DOI 10.1007/BF03258235, 10.1007/BF03258235]
[2]   LOPERAMIDE - SURVEY OF STUDIES ON MECHANISM OF ITS ANTIDIARRHEAL ACTIVITY [J].
AWOUTERS, F ;
MEGENS, A ;
VERLINDEN, M ;
SCHUURKES, J ;
NIEMEGEERS, C ;
JANSSEN, PAJ .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (06) :977-995
[3]   NEUROGENIC DIABETES-INSIPIDUS - MANAGEMENT WITH DDAVP (1-DESAMINO-8-D ARGININE VASOPRESSIN) [J].
COBB, WE ;
SPARE, S ;
REICHLIN, S .
ANNALS OF INTERNAL MEDICINE, 1978, 88 (02) :183-188
[4]   DESMOPRESSIN AND HEMOSTASIS [J].
DAVID, JL .
REGULATORY PEPTIDES, 1993, 45 (1-2) :311-317
[5]   Bioavailability of 1-deamino-8-D-arginine vasopressin with an enzyme inhibitor (aprotinin) from the small intestine in healthy volunteers [J].
FjellestadPaulsen, A ;
dAgayAbensour, L ;
Hoglund, P ;
Rambaud, JC .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (06) :491-495
[6]   METABOLISM OF VASOPRESSIN, OXYTOCIN, AND THEIR ANALOGS IN THE HUMAN GASTROINTESTINAL-TRACT [J].
FJELLESTADPAULSEN, A ;
SODERBERGAHLM, C ;
LUNDIN, S .
PEPTIDES, 1995, 16 (06) :1141-1147
[7]   PHARMACOKINETICS OF 1-DEAMINO-8-D-ARGININE VASOPRESSIN AFTER VARIOUS ROUTES OF ADMINISTRATION IN HEALTHY-VOLUNTEERS [J].
FJELLESTADPAULSEN, A ;
HOGLUND, P ;
LUNDIN, S ;
PAULSEN, O .
CLINICAL ENDOCRINOLOGY, 1993, 38 (02) :177-182
[8]   WATER-BALANCE HORMONES DURING LONG-TERM FOLLOW-UP OF ORAL DDAVP TREATMENT IN DIABETES-INSIPIDUS [J].
FJELLESTADPAULSEN, A ;
LABORDE, K ;
KINDERMANS, C ;
CZERNICHOW, P .
ACTA PAEDIATRICA, 1993, 82 (09) :752-757
[9]  
JACKSON EK, 1996, GOODMAN GILMANS PHAR, P715
[10]   PLASMA-CONCENTRATIONS OF 1-DEAMINO-8-D-ARGININE VASOPRESSIN AFTER INTRAGASTRIC ADMINISTRATION IN THE RAT [J].
LUNDIN, S ;
MELIN, P ;
VILHARDT, H .
ACTA ENDOCRINOLOGICA, 1985, 108 (02) :179-183